Antiemetics: Technologies and Global Markets

Report Highlights

The global market for antiemetics reached $4.1 billion in 2017 and should reach $5.9 billion by 2022, at a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2018-2023.

Report Includes

• 21 data tables and 15 additional tables
• Country specific data and analysis for United States, Canada, Mexico, France, Germany, UK, China, India, Japan, and Middle East and Africa
• An overview about current and future market potential for antiemetic drugs with special focus on competitive environment, pipeline drugs and blockbuster drugs
• Coverage of disease burden, regulatory environment, and novel technologies in the antiemetic drugs market
• Detailed description about vestibular disorder and increasing demand of innovative technology for treatment
• Exploration of the causes of emesis, usage of antiemetics and the types of products available to treat nausea and vomiting by each application segment
• Information about the launching of new drugs in each antiemetic drug class such as 5 HT₃ receptor antagonists, dopamine antagonists, NK₁ receptor antagonist, and so forth
• Detailed company profiles of major players in the market, including Abbott Laboratories, Daiichi Sankyo Company, Ltd., Merck & Co., Novartis AG, Sanofi Aventis and Teva Pharmaceutical Industries Ltd.

Report Scope

The report details the antiemetic drug market. The analysis highlights current and future market potential for antiemetic drug and presents a detailed review of pipeline drugs, blockbuster drugs, and challenges to market growth. The report also examines disease burden, regulatory environment, novel technologies, and market projections to 2023. Antiemetic drug market drivers, trends and potential regional market opportunities are also covered in this report.

The report details market shares of antiemetic drug class (5-HT₃ receptor antagonists, dopamine antagonists, steroid-corticosteroids, benzodiazepines, NK₁ receptor antagonist, antihistamines, cannabinoids, and anticholinergic) and geographic market segmentation of overall market; global market share by applications, with special emphasis on developed and underdeveloped geographic regions. For market estimates, data has been provided for 2017, as base year, 2018 and forecast for 2023.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
• Metal-organic Frameworks: Global Markets (AVM200B)
• Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets (PHM204C)
• Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)
• Surgical Equipment: Technologies and Global Markets (HLC154C)